934 Spam-Free Article(s) Found
Symbol Name Last Close Mkt Cap DailyStocks'
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Friday’s Close
MRK Merck & Company, Inc. $70.42 $187.28B N/A
Article Searches
Pfizer's Epogen Biosimilar Gets Positive FDA Committee Vote http://www.zacks.com/stock/news/262073/pfizers-epogen-biosimilar-gets-positive-fda-committee-vote?cid=CS-ZC-FT-262073 May 26, 2017 - Pfizer, Inc. (PFE) announced that an FDA advisory committee has recommended approval of its biosimilar version of ESA Epogen and Procrit.
Celldex's Immuno-Oncology Pipeline Continues to Impress http://www.zacks.com/stock/news/262070/celldexs-immuno-oncology-pipeline-continues-to-impress?cid=CS-ZC-FT-262070 May 26, 2017 - On May 25, we issued an updated research report on Hampton, NJ-based Celldex Therapeutics, Inc. (CLDX).
The Zacks Analyst Blog Highlights: Merck, 3M, United Technologies, Ford Motor and Humana http://www.zacks.com/stock/news/262005/the-zacks-analyst-blog-highlights-merck-3m-united-technologies-ford-motor-and-humana?cid=CS-ZC-FT-262005 May 26, 2017 - The Zacks Analyst Blog Highlights: Merck, 3M, United Technologies, Ford Motor and Humana
Here's How the FDA Just Helped Trump Deliver on a Big Promise https://www.fool.com/investing/2017/05/26/heres-how-the-fda-just-helped-trump-deliver-on-a-b.aspx?source=iedfolrf0000001 May 26, 2017 - A groundbreaking cancer drug approval may not have been what Trump had in mind, but a major restraint has indeed been slashed.
UnitedHealth's (UNH) Business Unit Collaborates with Merck http://www.zacks.com/stock/news/262108/unitedhealths-unh-business-unit-collaborates-with-merck?cid=CS-ZC-FT-262108 May 26, 2017 - UnitedHealth Group, Inc.???s (UNH) information and technology-enabled health services business "Optum" recently announced its collaboration with Merck & Co. Inc (MRK).
Merck (MRK) Buys Rights to Anti-tau Antibody for Alzheimer http://www.zacks.com/stock/news/262079/merck-mrk-buys-rights-to-anti-tau-antibody-for-alzheimer?cid=CS-ZC-FT-262079 May 26, 2017 - Merck & CO, Inc. (MRK) announced that it has bought exclusive worldwide license from Teijin Pharma for the development, manufacture and commercialization of an investigational preclinical anti-tau antibody.
Pharma Stock Roundup: Label Expansion for Merck Drug, Aerie Up On Eye Data http://www.zacks.com/stock/news/262023/pharma-stock-roundup-label-expansion-for-merck-drug-aerie-up-on-eye-data?cid=CS-ZC-FT-262023 May 26, 2017 - Merck (MRK) got another approval for Keytruda while Aerie shot up on positive data.
New Stock Research Reports for Merck, 3M and United Technologies http://www.zacks.com/research-daily/115235/new-stock-research-reports-for-merck-3m-and-united-technologies?cid=CS-ZC-FT-115235 May 25, 2017 - New Stock Research Reports for Merck, 3M and United Technologies
Radius Health Osteoporosis Drug Positive in Phase III Study http://www.zacks.com/stock/news/261886/radius-health-osteoporosis-drug-positive-in-phase-iii-study?cid=CS-ZC-FT-261886 May 25, 2017 - Radius Health, Inc. (RDUS) announced positive data from the ACTIVExtend study on Tymlos demonstrating significant reduction (84%) in the incidence of new vertebral fractures compared to placebo when dosed daily for 43 months.
Merck & Co (MRK) Investor Presentation - Slideshow https://seekingalpha.com/article/4076168-merck-and-co-mrk-investor-presentation-slideshow?source=feed_sector_healthcare May 24, 2017 - The following slide deck was published by Merck & Co Inc. in conjunction with this event.

Pages: 1...7778798081828384858687...94

<<<Page 82>